VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Pancreatic adenocarcinoma
Preclinical
Biologic
A
Assistance Publique - Hôpitaux de Paris
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pancreatic Tumors
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pancreatic Tumors
Preclinical
Recruiting
Clinical
Trials by Indication
[1]
Pancreatic Tumors
1 trial
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
Recruiting
·
A
Assistance Publique - Hôpitaux de Paris
·
N/A
·
NCT05794048
·
300 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Pancreatic adenocarcinoma. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Pancreatic adenocarcinoma compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Pancreatic adenocarcinoma. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
A
Assistance Publique - Hôpitaux de Paris
Related News